Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC) [Phase 2]

View source ↗

Summary

This is an update on a Phase 2 clinical trial evaluating the efficacy and safety of plitidepsin in adults with post-COVID-19 condition, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection
• Post-covid-19 Condition

Drugs mentioned

• Plitidepsin (plitidepsin)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: Post COVID-19 Condition, Long COVID Syndrome | Phase 2 | Status: RECRUITING